Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

IMMX

Immix Biopharma Inc

May 27 • 12:21PM ET

9.47

+0.63 7.13 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: COGT NUVB CCCC KURA FATE

| Held by: VTI VXF IWC AVSC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.92	Insider Own	24.07%	Shs Outstand	53.01M	Perf Week	6.88%
Market Cap	515.28M	Forward P/E	-	EPS next Y	-0.65	Insider Trans	0.01%	Shs Float	41.32M	Perf Month	-0.63%
Enterprise Value	425.74M	PEG	-	EPS next Q	-0.18	Inst Own	49.02%	Short Float	7.31%	Perf Quarter	8.23%
Income	-34.98M	P/S	-	EPS this Y	21.53%	Inst Trans	3.81%	Short Ratio	3.26	Perf Half Y	118.71%
Sales	0.00M	P/B	5.95	EPS next Y	7.28%	ROA	-60.47%	Short Interest	3.02M	Perf YTD	81.07%
Book/sh	1.59	P/C	5.69	EPS next 5Y	39.20%	ROE	-74.47%	52W High	11.61 -18.43%	Perf Year	380.71%
Cash/sh	1.66	P/FCF	-	EPS past 3/5Y	-12.81% -43.32%	ROIC	-41.02%	52W Low	1.87 406.42%	Perf 3Y	441.14%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.95% 8.54%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-27.17%	Oper. Margin	-	ATR (14)	0.79	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.76	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	50.91	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.76	EPS Q/Q	-19.16%	SMA20	0.12%	Beta	0.10	Target Price	18.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	0.66%	Rel Volume	2.00	Prev Close	8.84
Employees	21	LT Debt/Eq	0.01	Earnings	Feb 25	SMA200	63.34%	Avg Volume	926.72K	Price	9.47
IPO	Dec 16, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-83.03% -	Trades		Volume	862,545	Change	7.13%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)